These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 9678795

  • 41. Unrelated donor cord blood transplantation in adults with chronic myelogenous leukemia: results in nine patients from a single institution.
    Sanz GF, Saavedra S, Jiménez C, Senent L, Cervera J, Planelles D, Bolufer P, Larrea L, Martín G, Martínez J, Jarque I, Moscardó F, Plumé G, Andreu R, de la Rubia J, Barragán E, Solves P, Soler MA, Sanz MA.
    Bone Marrow Transplant; 2001 Apr; 27(7):693-701. PubMed ID: 11360108
    [Abstract] [Full Text] [Related]

  • 42. Validation of the EBMT risk score in chronic myeloid leukemia in Brazil and allogeneic transplant outcome.
    De Souza CA, Vigorito AC, Ruiz MA, Nucci M, Dulley FL, Funcke V, Tabak D, Azevedo AM, Byington R, Macedo MC, Saboya R, Penteado Aranha FJ, Oliveira GB, Zulli R, Martins Miranda EC, Azevedo WM, Lodi FM, Voltarelli JC, Simões BP, Colturato V, De Souza MP, Silla L, Bittencourt H, Piron-Ruiz L, Maiolino A, Gratwohl A, Pasquini R.
    Haematologica; 2005 Feb; 90(2):232-7. PubMed ID: 15710577
    [Abstract] [Full Text] [Related]

  • 43. Long term follow up after allogeneic stem cell transplantation for chronic myelogenous leukemia.
    Reiter E, Greinix HT, Brugger S, Keil F, Rabitsch W, Mannhalter C, Schwarzinger I, Höcker P, Fischer G, Dieckmann K, Hinterberger W, Linkesch W, Schneider B, Lechner K, Kalhs P.
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S86-8. PubMed ID: 9916646
    [Abstract] [Full Text] [Related]

  • 44. Clinical value of quantitative long-term assessment of bcr-abl chimeric transcript in chronic myelogenous leukemia patients after allogeneic bone marrow transplantation.
    Martinelli G, Montefusco V, Testoni N, Amabile M, Saglio G, Ottaviani E, Terragna C, Bonifazi F, Rosti G, Bandini G, Tura S.
    Haematologica; 2000 Jun; 85(6):653-8. PubMed ID: 10870124
    [Abstract] [Full Text] [Related]

  • 45. [Chronic myeloid leukemia].
    Gaiger A, Hinterberger W.
    Wien Med Wochenschr; 1991 Jun; 141(9-10):195-8. PubMed ID: 1949841
    [Abstract] [Full Text] [Related]

  • 46. Allogeneic bone marrow transplantation for chronic myeloid leukemia in childhood: a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
    Millot F, Esperou H, Bordigoni P, Dalle JH, Michallet M, Michel G, Bourhis JL, Kuenz M, Blaise D, Garban F, Plouvier E, Rome A, Guilhot J, Guilhot F.
    Bone Marrow Transplant; 2003 Nov; 32(10):993-9. PubMed ID: 14595387
    [Abstract] [Full Text] [Related]

  • 47. Effects of age on prognosis with imatinib mesylate therapy for patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
    Cortes J, Talpaz M, O'Brien S, Giles F, Beth Rios M, Shan J, Faderl S, Garcia-Manero G, Ferrajoli A, Wierda W, Kantarjian H.
    Cancer; 2003 Sep 15; 98(6):1105-13. PubMed ID: 12973833
    [Abstract] [Full Text] [Related]

  • 48. [Developments in the treatment of patients with chronic myeloid leukemia].
    Cornelissen JJ, Löwenberg B.
    Ned Tijdschr Geneeskd; 1997 Oct 04; 141(40):1904-9. PubMed ID: 9550736
    [Abstract] [Full Text] [Related]

  • 49. A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase.
    Elmaagacli AH, Runkel K, Steckel N, Opalka B, Trenschel R, Seeber S, Schaefer UW, Beelen DW.
    Bone Marrow Transplant; 2001 Apr 04; 27(8):809-15. PubMed ID: 11477437
    [Abstract] [Full Text] [Related]

  • 50. The graft-versus-leukemia effect of nonmyeloablative stem cell allografts may not be sufficient to cure chronic myelogenous leukemia.
    Sloand E, Childs RW, Solomon S, Greene A, Young NS, Barrett AJ.
    Bone Marrow Transplant; 2003 Nov 04; 32(9):897-901. PubMed ID: 14561990
    [Abstract] [Full Text] [Related]

  • 51. [Treatment of leukemia relapsed after allogenic bone marrow transplantation with donor lymphocyte infusion: report of 11 cases].
    Sanz Rodríguez C, Steegmann JL, Granda A, de la Cámara R, Figuera A, Arranz R, Gómez-García de Soria V, Alegre A, Fernández-Rañada JM.
    Sangre (Barc); 1999 Dec 04; 44(6):456-63. PubMed ID: 10822760
    [Abstract] [Full Text] [Related]

  • 52. Detection of residual leukaemia more than 10 years after allogeneic bone marrow transplantation for chronic myelogenous leukaemia.
    van Rhee F, Lin F, Cross NC, Reid CD, Lakhani AK, Szydlo RM, Goldman JM.
    Bone Marrow Transplant; 1994 Oct 04; 14(4):609-12. PubMed ID: 7858536
    [Abstract] [Full Text] [Related]

  • 53. [The analysis of failures in the treatment of children with chronic myelocytic leukemia in the studies of Polish pediatric leukemia/ lymphoma group].
    Chybicka A, Bogusławska-Jaworska J, Kałwak K, Turkiewicz D, Armata J, Balcerska A, Cwiklińska M, Hicke-Roberts A, Kaczmarek-Kanold M, Kołecki P, Kowalczyk J, Krauze A, Matysiak M, Płoszyńska A, Rokicka-Milewska R, Sońta-Jakimczyk D, Sikorska-Fic B, Wiśniewska-Slusarz H, Wysocki M, Wachowiak J.
    Wiad Lek; 1998 Oct 04; 51 Suppl 4():33-9. PubMed ID: 10731941
    [Abstract] [Full Text] [Related]

  • 54. Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation.
    Michallet M, Perrin MC, Belhabri A, Molina L, Nicolini F, Tigaud JD, Sotto JJ, Guyotat D, Fière D, Archimbaud E.
    Bone Marrow Transplant; 1999 Jan 04; 23(2):145-50. PubMed ID: 10197799
    [Abstract] [Full Text] [Related]

  • 55. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: a focus on the incidence of graft-vs.-host disease and relapse.
    Ustün C, Arslan O, Beksaç M, Koç H, Gürman G, Ozçelik T, Yilmaz B, Ilhan O, Akan H, Ozcan M, Demirer T, Uysal A, Konuk N, Arat M, Dilek I, Celebi H, Coskun HS.
    Biol Blood Marrow Transplant; 1999 Jan 04; 5(1):28-35. PubMed ID: 10232738
    [Abstract] [Full Text] [Related]

  • 56. Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the international bone marrow transplant registry.
    Giralt S, Szydlo R, Goldman JM, Veum-Stone J, Biggs JC, Herzig RH, Klein JP, McGlave PB, Schiller G, Gale RP, Rowlings PA, Horowitz MM.
    Blood; 2000 Jan 15; 95(2):410-5. PubMed ID: 10627443
    [Abstract] [Full Text] [Related]

  • 57. Intensive treatment in order to minimize the Ph-positive clone in CML. Danish-Swedish CML Group.
    Simonsson B, Oberg G, Björeman M, Björkholm M, Carneskog J, Gahrton G, Hast R, Karl H, Lanng-Nielsen J, Löfvenberg E, Malm C, Turesson I, Udén AM, Vilén L, Weis-Bjerrum O.
    Bone Marrow Transplant; 1996 May 15; 17 Suppl 3():S63-4. PubMed ID: 8769705
    [Abstract] [Full Text] [Related]

  • 58. [Treatment of chronic myeloid leukemia in children and adolescents--concept of the multicenter pilot study CML-ped].
    Suttorp M, Lion T, Creutzig U, Klingebiel T, Gadner H.
    Klin Padiatr; 1996 May 15; 208(4):242-9. PubMed ID: 8926690
    [Abstract] [Full Text] [Related]

  • 59. [Leukocyte transfusion as therapy of recurrent CML after allogenic bone marrow transplantation].
    Wiesneth M, Hertenstein B, Bunjes D, Novotny J, Stefanic M, Heinze B, Schreiner T, Kubanek B, Heimpel H, Arnold R.
    Beitr Infusionsther Transfusionsmed; 1994 May 15; 32():276-80. PubMed ID: 9480108
    [Abstract] [Full Text] [Related]

  • 60. [Autologous bone marrow transplantation in chronic myelogenous leukemia].
    Ogura H, Shirafuji N.
    Rinsho Ketsueki; 1991 Apr 15; 32(4):386-90. PubMed ID: 2067083
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.